Mechanisms and Data in One Discovery Pipeline

The twelfth embodiment in the consolidated patent application 19/540,453 is a Parkinson’s cure discovery method. It identifies compounds for dopamine neuron regeneration, alpha-synuclein aggregation prevention, mitochondrial function restoration, neuroinflammation reduction, and oxidative stress protection. The method uses probability and synthesis data and identifies mechanisms such as dopamine synthesis support, glutathione system support, and BDNF enhancement.

Like the diabetes and Alzheimer’s embodiments, the Parkinson’s method is built on the Alchemy probability data system. The same database and API can feed multiple disease pipelines. The patent specifies the mechanisms (dopamine, alpha-synuclein, mitochondrial, neuroinflammation, oxidative stress) and the kind of support (dopamine synthesis, glutathione, BDNF), so that the method is reproducible and licensable.

Three Neurological Targets, One Portfolio

Diabetes (embodiment 10), Alzheimer’s (11), and Parkinson’s (12) form a therapeutic discovery cluster within the fifteen-invention portfolio. All three rely on probability and synthesis data; all three have flowcharts in the specification (Figures 10, 11, 12). A licensee interested in one can evaluate the others under the same application number and filing date.

Application # 19/540,453, Confirmation # 1134, Patent Center # 74480330. Filed February 13, 2026. Payment receipt on file (USPTO).

Source: US Patent Application 19/540,453, Section 8.12; USPTO electronic payment receipt.

Masonry view